|
GRI GRI Bio Inc 1824293 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-1,643,000.00 |
| Balance Sheet |
|
Current Assets
|
$11,334,000.00 |
|
Assets
|
$11,380,000.00 |
|
Current Liabilities
|
$1,100,000.00 |
|
Liabilities
|
$1,100,000.00 |
|
Equity
|
$10,280,000.00 |
|
Shares Out
|
2186115.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,131,000.00 |
|
Investing Cash Flow
|
$-3,000.00 |
| Market Analysis |
Market Cap
|
$3,650,812.05 |
|
Price
|
$1.67 |
|
BVPS
|
4.70 |
|
PB
|
0.36 |
|
EPS
|
-0.91 |
|
FCF
|
$-5,134,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:04 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:53 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view GRI documents filed with the SEC.
GRI Filings
Clear
